Matrix metalloproteinases: roles in cancer and metastasis

Barbara Fingleton1

  • 1Dept of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Barbara.fingleton@vanderbilt.edu

Insights

Matrix metalloproteinases (MMPs) are crucial in cancer progression, impacting all stages. Understanding their diverse roles is key to developing effective cancer therapies, as broad inhibition has shown limited success.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) are extracellular proteinases involved in physiological processes and diseases like cancer.
  • Extensive research invested in MMP inhibitors for cancer therapy yielded disappointing clinical trial results.
  • This necessitates a re-evaluation of MMP functions in cancer, moving beyond earlier assumptions.

Purpose of the Study:

  • To summarize recent findings on MMP functions in cancer development and progression.
  • To contextualize these findings within the broader understanding of MMPs' roles.
  • To highlight the importance of understanding MMPs' diverse functions and interactions for therapeutic strategies.

Main Methods:

  • Review of recent scientific literature on matrix metalloproteinases in cancer.
  • Analysis of MMPs' roles across all stages of tumor progression.
  • Examination of MMPs' substrate processing and their dual pro- and anti-tumorigenic effects.
  • Investigation of interactions between MMPs and other proteinases in tumor biology.

Main Results:

  • MMPs contribute to every stage of tumor progression, not solely later stages.
  • MMP activity can exert both pro-tumorigenic and anti-tumorigenic effects depending on substrate processing.
  • Broad inhibition of MMPs may lead to adverse outcomes in certain cancer contexts.
  • Interactions between MMPs and other proteinases are critical in tumor biology.

Conclusions:

  • A comprehensive understanding of MMPs' multifaceted roles is essential for effective cancer therapy.
  • Targeting MMPs requires a nuanced approach, considering their diverse functions and interactions.
  • Future therapeutic strategies should account for the complex biology of MMPs in cancer progression.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...